Moderna Secures Tax Incentives with Assistance from Business Development Strategies, Inc.
The clinical stage biotechnology company, Moderna, Inc., expanded South of Boston and opened a 200,000sf biomanufacturing facility with help, in part, from a generous tax incentives package identified, negotiated and secured by Lynn Tokarczyk and Business Development Strategies, Inc. (BDS). Moderna’s relocation plan included the retention and relocation of 100 jobs from Cambridge to Norwood, creation of 120 new jobs and investment of $110 million in the Town.
“Lynn Tokarczyk and the BDS team delivered incentives to Moderna on a fast track in order to meet our corporate real estate timeline,” says Stephen Harbin, former Senior Vice President, Manufacturing and Operations. “We were fortunate to have a highly-regarded firm represent our incentives project.”
“The Moderna project offered an exciting opportunity for us to establish Norwood as a future hub for the life science industry and put the Town on the map,” says John Carroll, former Norwood General Manager. “We look forward to partnering with Moderna as they expand in the community.”